De-extinction Gene Editing CRISPR Technology CRISPR Genetically Modified Organisms Xenotransplantation Transgenic Organisms Extinct Species Species Resurrection Xenotransplantation Research Gene Modification Plant Genetics Animal Genetics Synthetic Biology Species Revival Cloning Crop Improvement Mammoth Resurgence De-extinction Projects Conservation Organ Transplantation Gene Therapy Electroporation Genetically Engineered Mice Biocontainment CRISPR/Cas9 Animal Genetic Engineering Transgenic Animals Genetic Modification of Pig Kidneys Glowing Blue Chip Technology Hybrid Brain Tissue CRISPR-Cas9 Technology DNA Reconstruction Extinction Hybrid Species Bacteriophages Mitochondrial DNA Editing Addiction Research Genetically Edited Animals Applications in Medicine Species Mutation Genome Synthesis Mutations CRISPR/Cas Extinction Reversal AI in Genetic Engineering Transgenic Plants Xenogeneic Organs Cell Engineering Plant Biotechnology Cell Transformation Transcriptional Condensates Microbial Production Ethics of Genetic Engineering CAR-T Cells Organ Rejection Toxoplasma gondii Genome Editing Induced Pluripotent Stem Cells COVID-19 Consumer Applications CRISPR-Cas Technology Crispr-Cas9 Technology Synthetic Circuits Biological Pest Control Insect Genetics Biocontrol Methods Mosquito Control Imprinting Genes Bipaternal Reproduction Imprinted Genes Crop Modification
New Nature papers detail early biomarkers plus FDA‑approved therapies to guide upcoming xenotransplant trials.